startups

Medtech Trends to Watch in 2020
Medtech Trends to Watch in 2020
Medical Devices and Diagnostics Industry
devices
digital health
5G
wearables
data
robotics
personalized medicine
IVDs
homecare
sterlization
startups
regulatory
Flag link:
How big pharma and startups can learn from each other
How big pharma and startups can learn from each other
Pharmaforum
startups
Big Pharma
digital pharma
Flag link:
Social connections first, science second: How biotech’s recipe for success has its limits
Social connections first, science second: How biotech’s recipe for success has its limits
Stat
biotech
startups
social capital
social connections
Flag link:
With Ex-Medivation Exec Hung at Helm, Nuvation Nabs $275M for Cancer
With Ex-Medivation Exec Hung at Helm, Nuvation Nabs $275M for Cancer
Xconomy
David Hung
oncology
startups
R&D
Nuvation Bio
Flag link:
San Diego upstart debuts discovery engine that puts a twist to protein degradation
San Diego upstart debuts discovery engine that puts a twist to protein degradation
Endpoints
protein degradation
Plexium
startups
Flag link:
Cell therapy startup raises $16 million to fund its quest for the Holy Grail in regenerative medicine
Cell therapy startup raises $16 million to fund its quest for the Holy Grail in regenerative medicine
Endpoints
cell therapy
startups
Mogrify
Flag link:
An AI startup, led by 23andMe veteran Andy Page, tries to take better pictures of the heart
An AI startup, led by 23andMe veteran Andy Page, tries to take better pictures of the heart
Stat
Andy Page
startups
cardiac imaging
artificial intelligence
Flag link:
The Creation Of Biotech Startups: Evolution Not Revolution
The Creation Of Biotech Startups: Evolution Not Revolution
Forbes
biotech
startups
Flag link:
One health care startup at a time, this venture capitalist wants to harness the investing power of women
One health care startup at a time, this venture capitalist wants to harness the investing power of women
Stat
venture capital
biotech
startups
Women's Health
Flag link:
Boston Startup Signs Up Millions For Lower Prescription Drug Costs
Boston Startup Signs Up Millions For Lower Prescription Drug Costs
Forbes
SingleCare
startups
drug pricing
Flag link:
How one Boston startup rode the diabetes investment wave to raise $126M
How one Boston startup rode the diabetes investment wave to raise $126M
Bizjournals
Beta Bionics
type 1 diabetes
startups
devices
Flag link:
Tactiva Therapeutics — A Biotech Startup Focusing on the Future of Immunotherapy
Tactiva Therapeutics — A Biotech Startup Focusing on the Future of Immunotherapy
Persimmon Development
Tactiva Therapeutics
startups
biotech
immunotherapy
Flag link:
How Big Pharmas Simultaneously Repel And Embrace Innovation
How Big Pharmas Simultaneously Repel And Embrace Innovation
Forbes
innovation
digital pharma
startups
Flag link:
The Secret to Health Tech Startups Reaping Riches? Realism
The Secret to Health Tech Startups Reaping Riches? Realism
Forbes
startups
realism
data
Flag link:
The biotech era in late-stage drug R&D and marketing has arrived. And it looks like it’s here to stay
The biotech era in late-stage drug R&D and marketing has arrived. And it looks like it’s here to stay
Endpoints
R&D
biotech
startups
drug development
Flag link:
Genentech backs U.K. accelerator to help pre-A round startups
Genentech backs U.K. accelerator to help pre-A round startups
Fierce Biotech
Genentech
startups
Start Codon
Flag link:
Better Diabetes Care: Healthcare Startups Say They’ll Get Paid When Patients Get Better
Better Diabetes Care: Healthcare Startups Say They’ll Get Paid When Patients Get Better
Forbes
diabetes
value-based care
patients
startups
Flag link:
Entrepreneur First's Latest Demo Day Showcases Their Move Into Biotech
Entrepreneur First's Latest Demo Day Showcases Their Move Into Biotech
Forbes
biotech
startups
Entrepreneur First
Flag link:
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
Xconomy
CRISPR
Sherlock Biosciences
startups
diagnostics
Flag link:
Lundbeck fund backs a $50M launch round for SNIPR Biome, a new brand of CRISPR Cas biotech
Lundbeck fund backs a $50M launch round for SNIPR Biome, a new brand of CRISPR Cas biotech
Endpoints
Lundbeck
Lundbeck Foundation
startups
CRISPR
SNIPR Biome
Flag link:

Pages